Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Baricitinib is effective and safe for treating alopecia areata.

Upadacitinib effectively treats pyoderma gangrenosum.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Sintilimab treatment caused hair loss but led to complete tumor remission.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

The microneedle system effectively promotes hair growth for treating androgenic alopecia.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Targeting lipid metabolism can help treat advanced, resistant cancers.

The scalp lotion helped increase hair thickness in cancer patients undergoing chemotherapy.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

The new platinum complexes effectively increased survival in rats with tumors, despite some reversible side effects.